Cargando…

Framework for identifying drug repurposing candidates from observational healthcare data

OBJECTIVE: Observational medical databases, such as electronic health records and insurance claims, track the healthcare trajectory of millions of individuals. These databases provide real-world longitudinal information on large cohorts of patients and their medication prescription history. We prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozery-Flato, Michal, Goldschmidt, Yaara, Shaham, Oded, Ravid, Sivan, Yanover, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Research and Applications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886555/ https://www.ncbi.nlm.nih.gov/pubmed/33623890 http://dx.doi.org/10.1093/jamiaopen/ooaa048

Ejemplares similares

Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson’s Disease
por: Laifenfeld, Daphna, et al.
Publicado: (2021)

Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics
por: Cohen, Keira A., et al.
Publicado: (2016)

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
por: Fang, Jiansong, et al.
Publicado: (2022)

Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study
por: Gottlieb, Assaf, et al.
Publicado: (2017)

Inferring new relations between medical entities using literature curated term co-occurrences
por: Spiro, Adam, et al.
Publicado: (2019)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data
por: Reps, Jenna M, et al.
Publicado: (2018)

A system for identifying and investigating unexpected response to treatment
por: Ozery-Flato, Michal, et al.
Publicado: (2015)

DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data
por: Pacini, Clare, et al.
Publicado: (2013)

Telemedicine and healthcare disparities: a cohort study in a large healthcare system in New York City during COVID-19
por: Chunara, Rumi, et al.
Publicado: (2020)

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
por: Xu, Hua, et al.
Publicado: (2015)

Functional gene groups are concentrated within chromosomes, among chromosomes and in the nuclear space of the human genome
por: Thévenin, Annelyse, et al.
Publicado: (2014)

A conceptual framework for evaluating data suitability for observational studies
por: Shang, Ning, et al.
Publicado: (2017)

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2020)

Network medicine framework for identifying drug-repurposing opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2021)

Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates
por: Roundhill, Elizabeth Ann, et al.
Publicado: (2023)

ChemBioServer 2.0: an advanced web server for filtering, clustering and networking of chemical compounds facilitating both drug discovery and repurposing
por: Karatzas, Evangelos, et al.
Publicado: (2020)

Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy
por: Ozery-Flato, Michal, et al.
Publicado: (2011)

Impact of the COVID-19 Pandemic on Clinical Findings in Medical Imaging Exams in a Nationwide Israeli Health Organization: Observational Study
por: Ozery-Flato, Michal, et al.
Publicado: (2023)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021)

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension
por: Wu, Patrick, et al.
Publicado: (2022)

Integrated multisystem analysis in a mental health and criminal justice ecosystem
por: Falconer, Erin, et al.
Publicado: (2017)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
por: Shityakov, Sergey, et al.
Publicado: (2021)

Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
por: Sharma, Khushbu, et al.
Publicado: (2023)

Leveraging Devices, Data and Discovery for Smarter Healthcare in Japan
por: Sawa, Tomohiro
Publicado: (2011)

Asan Medical Information System for Healthcare Quality Improvement
por: Ryu, Hyeon Jeong, et al.
Publicado: (2010)

Implementation of Consolidated HIS: Improving Quality and Efficiency of Healthcare
por: Choi, Jinwook, et al.
Publicado: (2010)

diffloop: a computational framework for identifying and analyzing differential DNA loops from sequencing data
por: Lareau, Caleb A, et al.
Publicado: (2018)

nosoi: A stochastic agent‐based transmission chain simulation framework in r
por: Lequime, Sebastian, et al.
Publicado: (2020)

PiHelper: an open source framework for drug-target and antibody-target data
por: Aksoy, Bülent Arman, et al.
Publicado: (2013)

Aligning an interface terminology to the Logical Observation Identifiers Names and Codes (LOINC(®))
por: Nikiema, Jean Noël, et al.
Publicado: (2021)

Applying a socioecological framework to chronic disease management: implications for social informatics interventions in safety-net healthcare settings
por: Nguyen, Kim Hanh, et al.
Publicado: (2022)

Using Social Media Data to Identify Potential Candidates for Drug Repurposing: A Feasibility Study
por: Rastegar-Mojarad, Majid, et al.
Publicado: (2016)

Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19
por: Paul, Debarati, et al.
Publicado: (2021)

Transcriptomics-Guided In Silico Drug Repurposing: Identifying New Candidates with Dual-Stage Antiplasmodial Activity
por: Borba, Joyce V. B., et al.
Publicado: (2023)

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019)

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9oi9nq9c5omt2g72fv55r3bjh0